Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the Pet Cancer Therapeutics Market Achieve During 2025–2034, and What Does It Indicate?
The rapid expansion of the pet cancer therapeutics market in recent years has led to noteworthy growth in size. The forecast indicates an increase from $0.39 billion in 2024 to $0.43 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. This growth in the previous period is due to factors such as rising pet ownership, advancements in veterinary medical treatments, increased knowledge of pet health issues, the humanisation of pets, and the expansion of veterinary services.
Anticipating substantial development in the upcoming years, the pet cancer therapeutics market size is projected to surge to $0.65 billion in 2029, boasting a compound annual growth rate (CAGR) of 10.7%. The predicted escalation during the forecast period is linked to factors such as an increase in the elderly pet population, improvements in cancer therapies, a surge in veterinary oncology services, expansive pet insurance and healthcare initiatives, plus the worldwide development of pet care services. The period also foresees a flourishing trend in nutraceuticals and integrative therapies, greater access to targeted diagnostic tests, a collaboration of veterinary and human oncology fields, the introduction of innovative chemotherapeutic agents, as well as an upswing in awareness and education for pet owners.
Which Drivers Are Expected to Have the Greatest Impact on the pet cancer therapeutics Market’s Growth?
The rising expenses on pet healthcare is projected to fuel the growth of the pet cancer therapeutics market. The term pet healthcare expenditure covers the financial outlay on veterinary services, medicine, and other health-related costs for pets. The increased spending on pet healthcare embodies the evolving trend of pet owners’ readiness to put money into their pets’ health, which could result in a higher demand for pet cancer therapeutics. For example, the 2023 State of the Industry Report by the North American Pet Health Insurance Association (NAPHIA), a pet health insurance association in the US, shows that the total number of pets insured in the US by the end of 2022 amounted to 4.8 million, marking a 22% jump from 2021. Hence, the surge in pet healthcare expenditure is propelling the pet cancer therapeutics market.
Get Your Free Sample of the Global Pet Cancer Therapeutics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp
Who Are the Key Firms Paving the Way for Growth in the Pet Cancer Therapeutics Market?
Major companies operating in the pet cancer therapeutics market include:
• AB Science_x000D_
• Boehringer Ingelheim GmbH_x000D_
• Elanco Animal Health_x000D_
• ELIAS Animal Health_x000D_
• Zoetis Inc._x000D_
What Are the Most Influential Trends Currently Shaping the Pet Cancer Therapeutics Market?
Key players in the pet cancer therapeutics market are innovating with technologies such as epigenetic technology to boost the effectiveness and precision of cancer treatments, thereby enhancing the prognosis for pets with cancer. Epigenetic technology involves techniques that alter gene expression without modifying the underlying DNA sequence. This often impacts cell behavior and potential treatment results. For example, VolitionRx Limited, a multinational epigenetics company based in the US, introduced the Nu.Q Vet Cancer Test in April 2024. The test runs on the Element i+ Analyzer, delivering speedy results — usually within 6 minutes. It employs an enzyme-linked immunosorbent assay to identify circulating nucleosomes in the blood, which could signal the existence of cancer.
Get Instant Access to the Global Pet Cancer Therapeutics Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report
Which Industry Segments Are Leading the Development and Expansion of the Pet Cancer Therapeutics Market?
The pet cancer therapeutics market covered in this report is segmented –
1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
2) By Species: Dogs, Cats, Other Species
3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies
4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users
Subsegments:
1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy
2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy
3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy
4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options
Which Regions Are Essential for the Growth of the Pet Cancer Therapeutics Market?
North America was the largest region in the pet cancer therapeutics market in 2024. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Elements Shape the Definition of the Pet Cancer Therapeutics Market?
Pet cancer therapeutics involve the use of various treatments and medications to manage or cure cancer in pets. This therapeutics depends on several factors such as the type and stage of cancer, along with the pet’s age and overall health.
Browse Through More Similar Reports By The Business Research Company:
Probiotics In Animal Feed Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/probiotics-in-animal-feed-global-market-report
Animal Antibiotics and Antimicrobials Global Market Report 2024
Veterinary Pain Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
